Aran Nayebi jokes that his robot vacuum has a bigger brain than his two cats. But while the vacuum can only follow a preset ...

Five new animal species that camouflage themselves as excrement or bark reveal some of what still remains hidden in the world ...

A selective protein degradation system known as Golgi membrane-associated degradation (GOMED), which identifies and removes ...

About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...

In November 2025, a group of the world’s leading experts on ultra-processed foods (UPFs) came together to review the latest ...

Company to Initiate First-in-Human Phase 1 Clinical Trial in Q2 2026ROCKVILLE, Md.--(BUSINESS WIRE)--#Clinicaltrials--Immunomic Therapeutics, Inc. (“ITI”), a privately held clinical-stage ...

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...

A selective protein degradation system known as Golgi membrane-associated degradation (GOMED), which identifies and removes ...

Koch, who studied vision, thought that by measuring people's brain responses as they looked at special optical illusions, ...

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in ...

Multiple preservatives that are added to food products to lengthen their shelf life have significant associations with overall cancer development.